NutriBand (NTRB) Net Margin (2018 - 2026)
NutriBand (NTRB) posted Net Margin of 286.56% for Q2 2026, down 18.62% sequentially from 241.59% in Q1 2026, and down 7847.0% YoY from 3.7% in Q2 2025.
NutriBand (NTRB) Net Margin (2018 - 2026) Analysis & Trends
NutriBand has reported Net Margin for 9 years, with the latest figure at 286.56% in Q2 2026.
- Quarterly Net Margin fell 7847.0% year-over-year to 286.56% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 1658.53% (down 124270.0% YoY) and the FY2026 annual result came in at 1475.16%, down 98521.0% from the prior year.
- Net Margin slipped to 286.56% in Q2 2026 per NTRB's latest filing, from 241.59% in the prior quarter.
- Over five years, Net Margin peaked at 126.41% in Q3 2023 and troughed at 3825.92% in Q3 2025.
- A 5-year average of 574.46% and a median of 302.45% in 2023 frame the typical range for Net Margin.
- The sharpest annual moves came in 2022 and 2025: Net Margin surged 82097 bps in 2022, then plunged 344079 bps in 2025.
- Over 5 years, Net Margin stood at 174.03% in 2022, then slumped by 136 bps to 411.36% in 2023, then surged by 49 bps to 211.0% in 2024, then slumped by 430 bps to 1118.99% in 2025, then jumped by 74 bps to 286.56% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 286.56%, 241.59%, and 1118.99% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 12.74% |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | -16.51% |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -3.12% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 12.09% |
| 10 | NutriBand | 55.31 Mn | 51.30 Mn | 196,801.00 | -286.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -286.56% |
| Jan 31, 2026 | -241.59% |
| Oct 31, 2025 | -1,118.99% |
| Jul 31, 2025 | -3,825.92% |
| Apr 30, 2025 | -208.09% |
| Jan 31, 2025 | -858.75% |
| Oct 31, 2024 | -211.00% |
| Jul 31, 2024 | -385.13% |
| Apr 30, 2024 | -464.61% |
| Jan 31, 2024 | -358.54% |
| Oct 31, 2023 | -411.36% |
| Jul 31, 2023 | -126.41% |
| Apr 30, 2023 | -212.87% |
| Jan 31, 2023 | -318.33% |
| Oct 31, 2022 | -174.03% |
| Jul 31, 2022 | -227.71% |
| Apr 30, 2022 | -144.37% |
| Jan 31, 2022 | -766.11% |
| Oct 31, 2021 | -624.80% |
| Jul 31, 2021 | -243.25% |